21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION.

Slides:



Advertisements
Similar presentations
FDA QS reg/CLIA Comparison: Overview
Advertisements

PRINCIPLES OF A CALIBRATION MANAGEMENT SYSTEM
Biopharmaceutical Quality
Regulatory Auditing. Audit Areas Management Responsibility Auditing (internal and external) Design Control Document Control Purchasing Control Identification.
What is GARP®? GARP® is an Acronym for Generally Accepted Recordkeeping Principles ARMA understands that records must be.
Audit of IT Systems SARQA / DKG Scandinavian Conference, October 2002, Copenhagen Sue Gregory.
GMP Document and Record Retention
New GAMP Good Practice Guide for Electronic Record and Signature Compliance Arthur D. Perez, Ph.D. Chairman, GAMP Americas.
SITS:Vision Annual the Hilton Deansgate Hotel, Manchester Gary Williams – Business Development Director Electronic Evidence July 2011.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
Environmental Health and Safety Radiation Control and Radiological Services.
Industry Coalition on 21 CFR Part 11 Recommendations for Achieving Compliance with the Electronic Records and Electronic Signatures Regulation.
CDRH Software Regulation
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
11/2/991 CDER’s 21 CFR Part 11 Implementation Study Greg Brolund Associate Director, Office of Information Technology, CDER/FDA.
Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum 21 CFR Part 11 Considerations November 14, 2002.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
21 CFR Part 11 A Food Industry Perspective FDA Public Meeting June 11, 2004 Sia Economides Center Director Center for Development of Research Policy and.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Regulatory Overview.
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
MethodGXP The Solution for the Confusion.
Kyle McDuffie, Vice President Beckman User Meeting 2001 Delaware. Orlando. Holland. UK Instrument Integration and Regulatory Compliance.
Good Manufacturing Practices
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Top 10 Medical Device Citations
FDA Docket No. 2004N-0133 Themes for Renewal of 21 CFR Part 11 Rule & Guidance by Dr. Teri Stokes, GXP International
Good Laboratory Practice CFR 21 Part 58 A Review for OCRA US RAC Study Group September 2005 Ginger Clasby, MS Promedica International
Health Insurance Portability and Accountability Act of 1996 (HIPAA) Proposed Rule: Security and Electronic Signature Standards.
Lecture Topic 4: Good Manufacturing Practices (GMPs)
1 PAT and Biological Products Tom Layloff FDA-SGE Management Sciences for Health The views expressed here are those of the author and not necessarily.
PwC 21 CFR Part 11 – A Risk Management Perspective Patrick D. Roche 07 March 2003, Washington D.C.
Impact of FSMA on the Regulation of Domestic and Imported Animal Food by Daniel G. McChesney, Ph.D. at Wild Bird Feeding Industry 2011 Annual Meeting Naples,
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Inspection Part II.
Important informations
Products to X-ray People for Security Presented to the : Technical Electronic Product Radiation Safety Standards Committee May 22, 2002.
FDA Public Meeting on Electronic Records and Signatures June 11, 2004 Presentation of the Industry Coalition on 21CFR Part 11 Alan Goldhammer, PhD Chair.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Part 11, Electronic Records; Electronic Signatures
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
QSR and GLP What exactly are these?.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Inspection Part III.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
Minimizing the Risks of TSE Agents in Human Tissues Melissa A. Greenwald, M.D. Division of Human Tissues Office of Cellular, Tissue and Gene Therapies;
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
FDA Part 11 Public Meeting Washington, DC June 11, 2004 Paul D’Eramo Executive Director Worldwide Policy & Compliance Management Quality & Compliance Services.
FDA Public Meeting Electronic Records; Electronic Signatures Docket No. 2004N-0133 Madeleine Kennedy & Michael Rutherford Eli Lilly and Company 11 June.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
INTRODUCTION Quality System in Medical Devices ©2014 Salt Lake Community College. All rights reserved.
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
75 years of excellence Combination Products NEMA’s Comments for the Office of Combination Products Public Hearing Terry Sweeney, Philips Medical Systems.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Guidance Development Merton V. Smith, Ph.D., J.D. Director International Programs and Product Standards Center for Veterinary Medicine, FDA.
Get Complete File From exam-dumps.html exam-dumps.html.
© 2016 Chapter 6 Data Management Health Information Management Technology: An Applied Approach.
21 CFR PART 11.
FDA 21 CFR Part 11 Compliance
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Medicines Control Council (MCC) &
בקרה תוך שימוש ב 21CFR Part 11 / אילן שעיה סמארט לוג'יק
FDA 21 CFR Part 11 Overview June 10, 2006.
Good Laboratory Practice CFR 21 Part 58
Making Your IRBs and Clinical Investigators HIPAA-Ready
Medicines Control Council (MCC) &
Presentation transcript:

21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) RICHARD EATON - NEMA RAVI NABAR, PH.D. – EASTMAN KODAK

National Electrical Manufacturers Association (NEMA) - Largest U.S. trade association representing America’s electroindustry - Diagnostic Imaging and Therapy Systems Division of NEMA represents manufacturers of: X-ray, CT, diagnostic ultrasound, magnetic resonance, nuclear medicine imaging, radiation therapy and medical imaging informatics equipment - Member of Part 11 Coalition

OVERVIEW - Original intended objectives of Part 11 Regulations - “The Problem” – Part 11 Duplication of Predicate Rules - NEMA presentation addresses Question 3 – Part 11 Subpart B Electronic Records - Proposed Solution

Original intended key objectives of Part 11 Regulations - Retention/documentation of records - Integrity/security of Records - FDA Access to Records - Authentication of Electronic Signatures - Accountability for Maintaining Records System - Validation

“THE PROBLEM” DUPLICATION – PART 11 AND PREDICATE RULES - Part 11 Regulations’ Objectives covered by Predicate Rules - Part 11 Regulations are too prescriptive - Part 11 Regulations + Predicate Rules – Duplicative and Confusing - Duplicative Regulations are Contrary to “least burdensome” principles to minimize excess regulation

PROPOSED SOLUTIONS ALTERNATIVE A: – Withdraw Part 11 Regulations in favor of Predicate Rules ALTERNATIVE B: – Change Part 11 Regulations to “Guidance” document

PREDICATE RULES ADDRESS PART 11 OBJECTIVES PREDICATE RULES ADDRESS PART 11 OBJECTIVES - Quality System Regulation - Medical Device Reporting - Corrections and Removals - Good Laboratory Practices

QUALITY SYSTEM REGULATION DUPLICATED BY PART 11 REGS. * PART 11 REGS CFR 11.10(a) Validation of Systems - 21 CFR 11.10(b) Controls – Closed Systems -Generate copies of records for inspection - 21 CFR 11.10(c) Protection of Records to enable retrieval LIMIT ACCESS TO AUTHORIZED INDIVIDUALS OPERATIONAL SYSTEM CHECKS QSR REGULATION - 21 CFR (i) Production/Process Controls - 21 CFR – Document Controls - 21 CFR – General Requirements - 21 CFR , * Intent of Predicate Rules is the same as Part 11 Regulations, but less prescriptive

QUALITY SYSTEM REGULATION DUPLICATED BY PART 11 REGS. PART 11 REGS. -21 CFR 11.10(d) Limit Access to authorized individuals -21 CFR 11.10(e) Use of computer-generated audit trails QSR REGULATION -21 CFR Document Controls -21 CFR Mgmt. Responsibility -21 CFR Document Controls

QUALITY SYSTEM REGULATION COMPARED WITH PART 11 REGS. Part 11 REGS. -21 CFR 11.10(f) Operational checks -21 CFR 11.10(g) Authority checks -21 CFR 11.10(h) Device checks QSR REGULATION -21 CFR Prod./Process control -21 CFR Mgmt. responsibility -21 CFR Personnel

QUALITY SYSTEM REGULATION DUPLICATED BY PART 11 REGS. PART 11 REGS. -21 CFR 11.10(i) Education - personnel -21 CFR 11.10(j) Accountability -21 CFR 11.10(k) Controls – system documentation QSR REGULATION -21 CFR Personnel -21 CFR Mgmt. Responsibility -21 CFR Document Controls

MEDICAL DEVICE REPORTING REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(b) Controls – generate copies of records for inspection - 21 CFR 11.10(c) Protection of records to enable retrieval MDR REGULATION - 21 CFR Maintain Records

MEDICAL DEVICE REPORTING REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(b) Controls - 21 CFR 11.10(b) Controls - 21 CFR 11.10(k) Controls – System Documentation MDR REGULATION - 21 CFR Required Reports - 21 CFR Electronic Reporting - 21 CFR Written MDR Procedures

MEDICAL DEVICE REPORTING REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(e) Audit trails - 21 CFR 11.10(k) Controls – system documentation MDR REGULATION - 21 CFR File/Distributor Reports (MDR events)

CORRECTIONS AND REMOVALS REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(b) Controls - 21 CFR (c) Protection of Records CORRECT. AND REMOVALS REG CFR Maintain Records

CORRECTIONS AND REMOVALS REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(b) Controls CORRECT. AND REMOVALS REG CFR Corrections and Removals Reports

CORRECTIONS AND REMOVALS REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(b) Controls CORRECT. AND REMOVALS REG CFR FDA Access to Records

GOOD LABORATORY PRACTICE REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(b) Records for inspection - 21 CFR 11.10(i) Education/training of personnel GOOD LAB. PRACTICE REG CFR Inspection of records - 21 CFR Personnel – education and training

GOOD LABORATORY PRACTICE REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR ( c ) Protection of records - 21 CFR (k) Appropriate controls over system documentation GOOD LAB. PRACTICE REG CFR Study Director – responsibility for documentation

GOOD LABORATORY PRACTICE REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(g) authority system checks - 21 CFR 11.10(k) Appropriate controls over system documentation - 21 CFR Controls over open systems GOOD LAB. PRACTICE REG CFR Quality Assurance Unit

GOOD LABORATORY PRACTICE REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR ( c ) Controls over system documentation GOOD LAB. PRACTICE REG CFR Written standard operating procedures

GOOD LABORATORY PRACTICE REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10(c) Protection of records - 21 CFR 11.10(k) Appropriate controls over system documentation GOOD LAB. PRACTICE REG CFR Storage and retrieval of records

GOOD LABORATORY PRACTICE REGULATION COMPARED WITH PART 11 REGULATIONS PART 11 REGS CFR 11.10( c) Protection of records - 21 CFR 11.10(k) Appropriate controls for system documentation GOOD LAB. PRACTICE REG CFR Retention of records

PREDICATE RULES - Acceptance by FDA and Industry - Part of Established Product Approval Process - Part of Long-Established Medical Device GMP Practice - Adequately Protects Public Health - Comprehensive – Covers all phases of product design, development, manufacture and correction and problem reporting

CONCLUSION AND RECOMMENDATIONS - Part 11 Rules are duplicative, burdensome and too prescriptive - Withdraw Part 11 Regulations in favor of predicate rules - Convert Part 11 Regulations to a less prescriptive, risk-based guidance document - NEMA ‘s goal is to work with FDA to achieve a practical regulatory solution which will meet the objectives of both FDA and industry